176 related articles for article (PubMed ID: 17368035)
1. Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris.
Madikane VE; Bhakta S; Russell AJ; Campbell WE; Claridge TD; Elisha BG; Davies SG; Smith P; Sim E
Bioorg Med Chem; 2007 May; 15(10):3579-86. PubMed ID: 17368035
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique.
Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ
J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
4. Piperidinols that show anti-tubercular activity as inhibitors of arylamine N-acetyltransferase: an essential enzyme for mycobacterial survival inside macrophages.
Abuhammad A; Fullam E; Lowe ED; Staunton D; Kawamura A; Westwood IM; Bhakta S; Garner AC; Wilson DL; Seden PT; Davies SG; Russell AJ; Garman EF; Sim E
PLoS One; 2012; 7(12):e52790. PubMed ID: 23285185
[TBL] [Abstract][Full Text] [Related]
5. Analysis of β-amino alcohols as inhibitors of the potential anti-tubercular target N-acetyltransferase.
Fullam E; Abuhammad A; Wilson DL; Anderton MC; Davies SG; Russell AJ; Sim E
Bioorg Med Chem Lett; 2011 Feb; 21(4):1185-90. PubMed ID: 21251821
[TBL] [Abstract][Full Text] [Related]
6. Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars.
Westwood IM; Bhakta S; Russell AJ; Fullam E; Anderton MC; Kawamura A; Mulvaney AW; Vickers RJ; Bhowruth V; Besra GS; Lalvani A; Davies SG; Sim E
Protein Cell; 2010 Jan; 1(1):82-95. PubMed ID: 21204000
[TBL] [Abstract][Full Text] [Related]
7. In vitro anti-mycobacterial activities of three species of Cola plant extracts (Sterculiaceae).
Adeniyi BA; Groves MJ; Gangadharam PR
Phytother Res; 2004 May; 18(5):414-8. PubMed ID: 15174004
[TBL] [Abstract][Full Text] [Related]
8. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents.
Singh U; Akhtar S; Mishra A; Sarkar D
J Microbiol Methods; 2011 Feb; 84(2):202-7. PubMed ID: 21129420
[TBL] [Abstract][Full Text] [Related]
9. Dual inhibition of mycobacterial fatty acid biosynthesis and degradation by 2-alkynoic acids.
Morbidoni HR; Vilchèze C; Kremer L; Bittman R; Sacchettini JC; Jacobs WR
Chem Biol; 2006 Mar; 13(3):297-307. PubMed ID: 16638535
[TBL] [Abstract][Full Text] [Related]
10. Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria.
Pruksakorn P; Arai M; Kotoku N; Vilchèze C; Baughn AD; Moodley P; Jacobs WR; Kobayashi M
Bioorg Med Chem Lett; 2010 Jun; 20(12):3658-63. PubMed ID: 20483615
[TBL] [Abstract][Full Text] [Related]
11. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.
Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E
J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974
[TBL] [Abstract][Full Text] [Related]
13. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
15. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis.
Sandy J; Holton S; Fullam E; Sim E; Noble M
Protein Sci; 2005 Mar; 14(3):775-82. PubMed ID: 15722451
[TBL] [Abstract][Full Text] [Related]
16. Activity against Mycobacterium smegmatis and M. tuberculosis by extract of South African medicinal plants.
Mativandlela SP; Meyer JJ; Hussein AA; Houghton PJ; Hamilton CJ; Lall N
Phytother Res; 2008 Jun; 22(6):841-5. PubMed ID: 18412151
[TBL] [Abstract][Full Text] [Related]
17. Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria.
McGaw LJ; Lall N; Hlokwe TM; Michel AL; Meyer JJ; Eloff JN
Biol Pharm Bull; 2008 Jul; 31(7):1429-33. PubMed ID: 18591787
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal domain of OmpATb is required for membrane translocation and pore-forming activity in mycobacteria.
Alahari A; Saint N; Campagna S; Molle V; Molle G; Kremer L
J Bacteriol; 2007 Sep; 189(17):6351-8. PubMed ID: 17573469
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents.
Owen DJ; Davis CB; Hartnell RD; Madge PD; Thomson RJ; Chong AK; Coppel RL; von Itzstein M
Bioorg Med Chem Lett; 2007 Apr; 17(8):2274-7. PubMed ID: 17303419
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.
Seidel V; Taylor PW
Int J Antimicrob Agents; 2004 Jun; 23(6):613-9. PubMed ID: 15194133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]